Bioptimus Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $41.4M

  • Investors
  • 18

Bioptimus General Information

Description

Developer of a universal artificial intelligence foundation model designed to drive scientific research and biotechnological innovation. The company's model connects the different scales of biology with generative AI, from molecules to cells, tissues, and whole organisms and transforms multiscale data into actionable representations, enabling businesses to transform multiscale data into actionable representations to fuel breakthrough discoveries.

Contact Information

Website
www.bioptimus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 14/16 Building Poissonnière
  • 75009 Paris
  • France
Primary Industry
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 14/16 Building Poissonnière
  • 75009 Paris
  • France

Bioptimus Timeline

20242025
Date FoundedFinancing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioptimus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 14-Jan-2025 $41.4M Completed Startup
2. Accelerator/Incubator 01-Jan-2024 Completed Startup
1. Early Stage VC 19-Feb-2024 $35M $35M Completed Startup
To view Bioptimus’s complete valuation and funding history, request access »

Bioptimus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Ordinary
To view Bioptimus’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Bioptimus Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
Boom Capital Ventures Venture Capital Minority
Angel (individual) Minority
Hitachi Ventures Corporate Venture Capital Minority
Pomifer Capital Fund of Funds Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Bioptimus FAQs

  • When was Bioptimus founded?

    Bioptimus was founded in 2023.

  • Where is Bioptimus headquartered?

    Bioptimus is headquartered in Paris, France.

  • What industry is Bioptimus in?

    Bioptimus’s primary industry is Biotechnology.

  • Is Bioptimus a private or public company?

    Bioptimus is a Private company.

  • What is the current valuation of Bioptimus?

    The current valuation of Bioptimus is .

  • What is Bioptimus’s current revenue?

    The current revenue for Bioptimus is .

  • How much funding has Bioptimus raised over time?

    Bioptimus has raised $76.4M.

  • Who are Bioptimus’s investors?

    Andera Partners, Boom Capital Ventures, , Hitachi Ventures, and Pomifer Capital are 5 of 18 investors who have invested in Bioptimus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »